MiR-150 is a microRNA (miRNA) specifically expressed in mature lymphocytes, but not their progenitors. A top predicted target of miR-150 is c-Myb, a transcription factor controlling multiple steps of lymphocyte development. Combining loss-and gain-of-function gene targeting approaches for miR-150 with conditional and partial ablation of c-Myb, we show that miR-150 indeed controls c-Myb expression in vivo in a dose-dependent manner over a narrow range of miRNA and c-Myb concentrations and that this dramatically affects lymphocyte development and response. Our results identify a key transcription factor as a critical target of a stage-specifically expressed miRNA in lymphocytes and suggest that this and perhaps other miRNAs have evolved to control the expression of just a few critical target proteins in particular cellular contexts.
INTRODUCTION
B cell development and differentiation in mouse and man are complex processes starting in fetal liver and bone marrow with the proliferative expansion of progenitor cells that undergo sequential rearrangements of their antigen receptor genes to produce a diverse, clonally selected receptor repertoire. Cells expressing functional, nonselfreactive receptors are then positively selected into the peripheral pool of long-lived, mature B cells. This process of positive selection can follow distinct pathways, depending on environmental signals and, perhaps, properties of distinct classes of progenitor cells, to produce distinct subsets of mature, peripheral B cells. Major subsets of mature B cells are follicular B cells, mainly localized in B cell follicles in spleen and lymph nodes and responsible for classical, T cell-dependent (TD) antibody responses; marginal zone (MZ) B cells, localized in the marginal zone of the spleen and known for their ability to respond rapidly to infectious agents in the blood; and B1 cells, homing to the peritoneal and pleural cavities and representing an important source of ''natural'' antibodies in the blood as an evolutionarily selected first line of defense against pathogens. Follicular B and MZ B cells are also called B2 cells (Hardy and Hayakawa, 2001; Berland and Wortis, 2002; Pillai et al., 2005) .
Mature B cells are resting cells, whose numbers are kept constant in a first approximation throughout life, although there is a continuous influx of newcomers from the bone marrow, at least in the case of follicular and MZ B cells, and a continuous recruitment of cells into immune responses. These responses involve activation by antigen and various costimulatory molecules, cell proliferation, and differentiation into long-lived memory or terminally differentiated, antibody secreting plasma cells (Shapiro-Shelef and Calame, 2005) .
It has become clear over the last decades that the various phases of B cell development and response are under distinct programs of transcriptional control, which are activated in the cells by environmental cues (Schebesta et al., 2002) . A large set of transcription factors participate in this control together or in succession, and a key parameter in this interplay is their cellular concentrations, as documented perhaps most strikingly in the context of lineage commitment in early hematopoietic progenitors (Laiosa et al., 2006; Laslo et al., 2006) . Developmental processes in the hematopoietc system and perhaps in general may thus require rapid changes of transcription factor concentrations, a requirement that could best be met by mechanisms of posttranscriptional control. MiRNAs have recently emerged as key factors in the posttranscriptional control of intracellular protein concentrations in metazoan organisms (Bartel, 2004) . These $22 nt RNAs can repress protein expression by specifically targeting mRNAs for translational repression or degradation and would thus appear ideally suited to control rapid changes of protein concentrations in cells, as we expect them to be required in hematopoietic development. Certain miRNAs are indeed expressed in a stage-specific fashion in the hematopoietic system (Chen et al., 2004; Monticelli et al., 2005; Neilson et al., 2007) , and emerging evidence suggests that they can be involved in the control of lymphocyte development and function (Li et al., 2007; Thai et al., 2007; Rodriguez et al., 2007) .
We previously identified miR-150 as a miRNA selectively expressed in mature, resting B and T cells, but not their progenitors (Monticelli et al., 2005) . A top predicted target of miR-150 is the transcription factor c-Myb, which we had previously shown to be critically important for multiple steps of lymphocyte development and required for the generation of B1 cells (Bender et al., 2004; Thomas et al., 2005) . c-Myb is highly expressed in lymphocyte progenitors, downregulated upon maturation, and again upregulated after activation of the mature cells. Combining loss-and gain-of-function gene targeting approaches for miR-150 with conditional and partial ablation of c-Myb, we now show that miR-150 indeed controls c-Myb expression in vivo, that this interaction quantitatively explains the effect of ectopic miR-150 expression in B cell progenitors, and that miR-150 ablation in the mouse germline affects B cell response and subset differentiation as would at least in part be predicted from deregulated c-Myb expression. In a general way, these results support the concept that the physiological function of a given miRNA may lie in the control of the concentrations of just a few critical target proteins in particular cellular contexts.
RESULTS

Stage-Specific Expression of MiR-150 during Lymphocyte Development
To study biological functions of miRNAs in lymphocyte development, we searched for miRNAs specifically expressed in lymphocytes in a developmental stage-specific manner, assuming that such miRNAs likely have lymphocyte-specific functions. By combining expression profiling and northern blot analysis, we identified a few miRNAs meeting this criterion (Monticelli et al., 2005) . Among them is miR-150, a miRNA that is highly expressed in mature and resting lymphocytes, but not in their progenitors ( Figure 1A ). This stage-specific expression pattern suggests that miR-150 may play a role in lymphocyte development or function.
MiR-150 Targets the Transcription Factor c-Myb
To gain insights into the biological functions of miR-150, we performed bioinformatics analyses to identify potential targets, focusing on genes known to regulate lymphocyte development. c-Myb, an essential transcription factor for normal lymphocyte development (Bender et al., 2004; Thomas et al., 2005) , was among the top target genes predicted for miR-150 (Krek et al., 2005) . In addition, miR-150 ranks the highest among all miRNAs possibly targeting c-Myb (Tables S1 and S2 in the Supplemental Data available with this article online) . Interestingly, the pattern of c-Myb expression in lymphocyte development is complementary to that of miR-150, in that c-Myb is highly expressed in lymphocyte progenitors, downregulated upon maturation, and upregulated again after activation of the mature cells ( Figure 1A ) (Bender et al., 2004; Thomas et al., 2005) .
To test whether miR-150 indeed targets c-Myb, we performed reporter assays in cell culture and found that miR-150 overexpression in HEK293T cells reduced by a factor of seven the activity of a Renilla luciferase reporter gene containing the wild-type c-Myb 3 0 UTR, which harbors three putative miR-150 binding sites. In contrast, expression of the unrelated miR-191 had no significant effect on the expression of this reporter ( Figures 1B-1D ). As a reference, the activity of a Renilla luciferase reporter gene containing within its 3 0 UTR two sites perfectly complementary to miR-150 was 11-fold reduced upon miR-150 expression ( Figure 1D ). To demonstrate that the effect of miR-150 on the luciferase gene is dependent on the presence of the miR-150 binding sites, we generated a panel of reporter constructs containing the c-Myb 3 0 UTR with the miR-150 binding sites mutated individually or in combination ( Figure 1B) . Although the mutation of site 1 did not influence the inhibitory effect of miR-150 on reporter gene expression, mutation of sites 2 and 3 individually reduced the inhibitory effect to 2.5-to 3-fold, and mutation of both sites completely abolished the inhibitory effect, suggesting that these two sites function cooperatively in mediating c-Myb inhibition ( Figure 1E ). A close examination of these three sites revealed that only sites 2 and 3 are perfectly conserved across all mammals with genomic DNA sequences available, whereas site 1 is not. These observations hold true also when comparing these sites within a set of 12 metazoans, which include nonmammalian species (D. Grun and N.R., unpublished data). Moreover, sites 2 and 3 align perfectly with miR-150 at nucleotide positions 1-8, whereas site 1 does not ( Figure 1B) . Thus, our results confirm the idea that evolutionary conservation and a perfect match at nucleotide positions 1-8 are good indicators of functional miRNA binding sites (Lai, 2002; Lewis et al., 2003; Doench and Sharp, 2004; Brennecke et al., 2005; Xie et al., 2005; Krek et al., 2005) and establish that c-Myb is indeed a functional target of miR-150.
MiR-150 Deficiency Leads to B1 Cell Expansion and an Enhanced Humoral Immune Response
We have previously reported that B cell-specific deletion of the c-Myb gene leads to a severe block of B cell development at the pro-to pre-B transition and disappearance of one of the mature B cell subsets, the so-called B1 cells (Thomas et al., 2005) . If miR-150 indeed targets c-Myb in vivo, the predictions are that miR-150 deficiency will lead to a phenotype opposite to that caused by the deletion of c-Myb and that ectopic expression of miR-150 in B cell progenitors will result in a block of B cell development. We therefore used loss-and gain-of-function gene targeting approaches for miR-150 to study the functional interplay between miR-150 and c-Myb in vivo.
MiR-150 is encoded by an independent transcription unit downstream of the genes encoding ribosomal proteins L13a (Rpl13a) and S11 (Rps11) (UCSC Genome Browser [http://genome.ucsc.edu/cgi-bin/hgGateway] and Figure 2A ). We deleted a 679 bp miR-150-coding region by introducing loxP sites for Cre-mediated recombination at both ends ( Figure 2A ). Breeding to deleter-cre mice (Schwenk et al., 1995) , which express Cre recombinase early during embryogenesis, led to deletion of the miR-150-coding region and the pGK-Neo drug selection marker in the germline and the complete absence of miR-150 in homozygous mutant mice (mir150 À/À mice) (Figures 2A and 2B ). Mir150 À/À mice were viable, fertile, and morphologically normal. The development of T cells, follicular B cells, and MZ B cells was also normal (data not shown). However, in striking contrast to mice with a B cell-specific deletion of c-Myb (in which B1 cells are absent), splenic B1 cells were expanded 4-fold in number. In the peritoneal cavity, B1 cells were expanded in number by a factor of 2, with a Figure 2C ; data not shown) and are, therefore, B1a cells (Berland and Wortis, 2002) . Does miR-150 deficiency lead to c-Myb upregulation in the various lymphocyte subsets? Western blot analysis of purified B1a cells from peritoneal cavity, B2 cells, and CD4 T cells from spleen and peripheral lymph nodes showed that c-Myb protein levels were too low to be detectable in these cells from both mir150
À/À and wild-type mice ( Figure S1A ). This is probably due to control of c-Myb gene expression at the transcriptional level, consistent with previous reports that low c-Myb messenger RNA (mRNA) levels were found in mature lymphocytes (Pauza, 1987; Golay et al., 1992; Bender et al., 2004; Thomas et al., 2005) . However, c-Myb mRNA is induced upon B and T cell activation and peaks at 32-48 hr after stimulation (Pauza, 1987; Golay et al., 1992) , when a significant amount of miR-150 is still present and could modulate c-Myb protein levels ( Figure 3A) . Indeed, the induction of c-Myb protein in mir150 À/À B cells upon IgM crosslinking was enhanced by a factor of 2.6, compared to controls ( Figure 3B ). A similar enhancement of c-Myb protein induction was observed when mir150 À/À CD4 T cells were activated ( Figure S1B ). This strongly suggests that miR-150 directly controls c-Myb expression in vivo, in accord with the reporter assays depicted in Figure 1 . Given the dependence of the B1 subset on c-Myb (Thomas et al., 2005) and indeed its precise dosage (see below, Figure 6 ), it seems likely, therefore, that the increased number of B1 cells in miR-150-deficient mice is due to deregulated c-Myb expression at some stage of development involving activation of these cells. B1 cells have been shown to produce a significant fraction of the ''natural'' antibodies in the blood (Forster and Rajewsky, 1987; Kroese et al., 1989; Fagarasan et al., 2000) . We therefore examined the serum immunoglobulin (Ig) levels in mir150 À/À mice to search for functional consequences of the expansion of B1 cells. Strikingly, the mutant animals exhibited a 9-fold increase in IgA, a 3-fold increase in IgG1, a 4-fold increase in IgG2b, and a 2-fold increase in IgM serum levels ( Figure 3D ). The dramatic increase in serum IgA levels is particularly intriguing, because in vitro class switch experiments have demonstrated that B1 cells switch eight times more efficiently from IgM to IgA production than follicular B cells (Kaminski and Stavnezer, 2006) . It is quite possible, however, that some of the enhancement of the serum immunoglobulin levels seen in the miR-150-deficient animals is due to enhanced responses of follicular B cells as well. Indeed, when miR-150 knockout mice were immunized with a T cell-dependent (TD) antigen, they produced three to four times more IgG1 antibodies than the controls ( Figure 3E ). TD antibody responses are typically produced by follicular B cells, not B1 cells. Enhanced c-Myb induction upon IgM crosslinking could contribute to both the observed increase in steady-state serum immunoglobulin levels and the enhanced TD response in the mutant animals, as higher c-Myb levels may promote the survival of activated B cells. c-Myb has been previously reported to promote lymphocyte survival by upregulating the prosurvival protein Bcl2 (Taylor et al., 1996; Salomoni et al., 1997) . Indeed, in cell culture experiments, we observed a modest increase of Bcl2 protein levels in activated mir150 À/À B cells on day 2 and a corresponding reduction in cell death as determined by measuring DNA content on day 3 after IgM crosslinking ( Figures 3B and 3C ), while proliferation and class switch recombination of B2 cells were normal ( Figures SF2 and SF3 ).
Ectopic MiR-150 Expression Impairs Lymphocyte Development
Having shown that miR-150 represses c-Myb protein levels in vivo and mir150 À/À mice display a phenotype opposite to that caused by ablation of c-Myb in the B cell lineage, we reasoned that ectopic expression of miR-150 in B cell progenitors would result in downregulation of c-Myb protein levels and a block in B cell development similar to that caused by B cell-specific deletion of c-Myb (Thomas et al., 2005) . This would also give us the opportunity to study the quantitative aspects of miRNA-target gene interaction by genetically manipulating the levels of the miRNA.
To test this idea, we inserted a genomic DNA fragment encoding miR-150, preceded by the synthetic CAG promoter and a loxP-flanked Neo-STOP cassette, into the ubiquitously expressed Rosa26 locus ( Figure 4A ). An frtflanked IRES-EGFP cassette was placed between the mir150 genomic DNA fragment and the polyadenylation signal (pA). Upon Cre-mediated excision of the Neo-STOP cassette (Schwenk et al., 1995) , the CAG promoter drives the production of both miR-150 and EGFP in all cells and tissues examined ( Figure 4B and Figure S4 ). We termed this mutant allele mir150-EGFP Tg. Ectopic expression of miR-150 in mir150-EGFP Tg thymocytes (used for convenience because of their low levels of endogenous miR-150 and their availability in large numbers) was 23% of the endogenous level in naive CD4 T cells, and expression almost doubled (to 43%) in mir150-EGFP Tg/Tg thymocytes. miR-150 expression was in the same range in bone marrow pro-B cells cultured in vitro (see below, Figure 5C ). Deletion of the IRES-EGFP cassette by Flpe (the resulting allele termed mir150 Tg) (Rodriguez et al., 2000) resulted in slightly increased miR-150 expression (30% in mir150 Tg and 55% in mir150 Tg/Tg thymocytes; Figures 4C and 4E) . These results demonstrate that in this experimental model the transgenic miRNA is expressed at moderate levels, below those of endogenous miR-150 in mature lymphocytes under physiological conditions. This is important, as we aimed at establishing a system of ectopic expression, not overexpression. When c-Myb protein levels were measured in thymocytes expressing different levels of miR-150, the average c-Myb protein levels were 70% in mir150-EGFP Tg/Tg and 65% in mir150 Tg/Tg thymocytes, compared to 100% in wild-type thymocytes, indicating that ectopic miR-150 expression reduces c-Myb protein levels in a dose-dependent manner ( Figures 4D and 4E) .
Mice ectopically expressing miR-150 were viable, fertile, and morphologically normal, but B cell development was dramatically impaired. There was also an impairment of T cell development, but this was less pronounced. We therefore focus in this paper mainly on the B cell lineage but provide some T cell-related results in the Supplemental Data. In animals carrying one copy of the mir150-EGFP Tg or mir150 Tg allele, the numbers of mature lymphocytes in the spleen were reduced at young age and became comparable to those of littermate controls only by 6-8 weeks ( Figure 4F and Figure S5A ). In mice carrying two copies of the mir150-EGFP Tg allele, the numbers of mature T cells were reduced at young age and became comparable to control levels at the age of 18-41 weeks ( Figures S5A and S5B ), whereas B cell numbers, especially B1 cell numbers, stayed lower than control levels during the same age range (Figures 4F and 4G) . mir150 Tg/Tg mice were severely lymphopenic over the entire time of observation ( Figure 4F and Figure S5A ). Analysis of bone marrow by flow cytometry revealed a significant block early during B cell development, at the pro-to pre-B cell transition, in both young and old animals alike ( Figure 4H and data not shown). A less pronounced block was apparent in the T cell lineage, at the double-negative 3 (DN3) to double-negative 4 (DN4) transition ( Figure S5C ). These results are in partial agreement with a study that appeared when this paper was written up, in which retroviral overexpression of miR-150 in hematopoietic progenitors led to a block of B, but not T, cell development (Zhou et al., 2007) . Complete deletion of c-Myb in B and T cell lineages causes more severe developmental blocks at exactly the same transition points (Bender et al., 2004; Thomas et al., 2005) , suggesting that the block in miR-150 transgenic mice is due to reduced c-Myb protein levels in lymphocyte progenitors. That this is indeed the case is experimentally verified further below (see Figure 6 ). The gradual increase of peripheral T and B cell numbers in the mutant animals likely reflects the accumulation of long-lived T and B cells over time, as it is often observed in mice in which lymphocyte development is compromised.
Ectopic MiR-150 Expression Increases Cell Death of In Vitro-Cultured Pro-B Cells
To test whether the phenotype seen in the mir150 transgenic mice is due to a lymphocyte autonomous mechanism and to better understand the block at the pro-to pre-B transition in these animals, we used an in vitro pro-B cell culture system, in which pro-B cells proliferate in an IL-7 and stroma cell-dependent manner (Rolink et al., 1991) . B lineage cells from the bone marrow were purified by magnetic cell sorting (MACS) using magnetic beads coated with anti-CD19 or B220 antibodies and cultured for up to 6 days. We observed a reduced cell output from the mir150-EGFP Tg/Tg cultures, while the cellular composition of the output of these cultures was comparable to that of wild-type cell cultures ( Figures S6A and S6B ). PKH26 Red labeling of transgenic and wild-type cells revealed no major difference in cell proliferation ( Figure S6C ). Staining with propidium iodide (PI), however, demonstrated an increase in the sub-G0 population in the mir150-EGFP Tg/Tg cultures, suggesting that increased cell death caused the reduced cell output ( Figure 5A ). We also tested mir150 Tg/Tg mice by culturing FACSsorted pro-B cells, to avoid heterogeneity among input cells. We again detected a markedly decreased output of cells from the mir150 Tg/Tg cultures compared to the controls, accompanied by a decrease in cell viability as determined by the Guava ViaCount assay (85% for wildtype versus 55% for mir150 Tg/Tg cultures) ( Figure 5B ). MiR-150 expression in the bulk-cultured mir150-EGFP Tg/Tg pro-B cells was 63% of that in splenic B cells, leading to a reduction of c-Myb protein by 34% compared to bulk-cultured wild-type pro-B cells ( Figure 5C ).
Small Changes of c-Myb Protein Levels
Have Severe Functional Consequences Is a 30%-35% reduction of c-Myb protein levels sufficient to cause the dramatic phenotype seen in the mir150 transgenic mice? We analyzed heterozygous c-Myb knockout mice to address this question. In thymocytes from these animals, the c-Myb protein level was reduced by about 26% ( Figures 6A and 6B) . Strikingly, the heterozygous mutant mice displayed a marked reduction of the numbers of mature B cells in the spleen at young age ( Figure 6C ), and a block at the pro-to pre-B transition as had been observed in mir150 Tg/Tg mice ( Figure 6D ). This developmental block had not been apparent in our original study (Thomas et al., 2005) , likely due to the mixed genetic background of the experimental animals used in those experiments. A reduction of pre-B cell numbers in the bone marrow persisted in the animals over time ( Figure S8 ), so that the normalization of lymphocyte numbers in the peripheral immune system at older age is likely due to the accumulation of long-lived mature cells. Furthermore, B1 cells in these mice were markedly reduced in the spleen and peritoneal cavity ( Figures 6E and 6F ). These results indicate that lymphocyte development is exquisitely sensitive to small changes of c-Myb protein levels, similar to the ones brought about by ectopically expressed miR-150 in the transgenic animals. Therefore, in a first approximation, the phenotype observed in the mir150 transgenic mice can be explained by the control of c-Myb expression by this miRNA, and this could equally be true for the B1 cell expansion and enhanced B cell response in the mir150 knockout mice. This is reminiscent of observations that small changes in the cellular concentrations of key transcription factors have severe consequences on the lineage commitment of early hematopoietic progenitors (Laslo et al., 2006) . 
DISCUSSION
In the present work we address the function of a miRNA, which is stage specifically expressed in lymphocyte development, by genetically manipulating its expression in gain-and loss-of-function experiments and by genetically identifying one of its bioinformatically predicted targets as a true, functionally critical target in the in vivo context. The results of the reporter assays and the enhanced c-Myb upregulation upon activation of mir150-deficient lymphocytes established that miR-150 directly regulates c-Myb protein levels through two conserved miR-150 binding sites in the 3 0 UTR of the c-Myb mRNA. That miR-150 indeed controls c-Myb levels in vivo was corroborated in experiments in which the miRNA was ectopically expressed at moderate levels in B cell progenitors, where it is normally not expressed, whereas c-Myb expression is high. This led to a miR-150 dose-dependent downregulation of c-Myb levels, and resulted in a partial block of B cell development and a reduction in B1 cell numbers. A similar phenotype was obtained when c-Myb levels were similarly reduced by partial ablation of c-Myb, in heterozygous c-Myb mutants. This result demonstrated that the partial block of B cell development through miR-150 expression was indeed due to c-Myb downregulation in a first approximation. The phenotype of miR-150 knockout mice, which we also generated, is compatible with the notion that c-Myb is the major target of miR-150 also in normal physiology. Here this miRNA is predominantly expressed in mature lymphocytes. Upon its genetic ablation, B1 cells, one of the subsets of mature B cells, expand in spleen and peritoneal cavity, a phenotype directly opposed to the B1 cell ablation seen upon B cell-specific c-Myb deletion (Thomas et al., 2005) . MiR-150 ablation also strikingly affected antibody production. Significantly higher levels of immunoglobulins of various classes were present in the blood of the mutant animals compared to controls. That this is partially connected to the B1 cell expansion in these mice is supported by the finding that the most drastic increase was seen for IgA, an isotype to whose expression B1 cells preferentially switch (Kaminski and Stavnezer, 2006) . However, the loss of miR-150 also enhances the antibody response to T cell-dependent antigen, which is classically mediated by B2 cells. We speculate that this may be due to the enhanced expression of c-Myb in those cells upon activation. This is supported by the increased expression levels of Bcl2, a direct c-Myb target gene, and the reduction of cell death that we have observed in activated mir150 À/À B cells upon IgM crosslinking. Our results do not exclude the possibility that other miR-150 target genes may also contribute to the phenotypes of mir150 À/À and miR-150 transgenic mice. We have examined the expression levels of Foxp1 and ZFP91, two predicted miR-150 target genes that are potentially functionally relevant, in mir150 À/À and miR-150 transgenic lymphocytes. Foxp1 is an essential regulator of early B cell development (Hu et al., 2006) , and ZFP91 is implicated in cell proliferation and survival (Unoki et al., 2003) . The expression levels of these two proteins were, however, not affected by the absence or ectopic expression of miR-150 in resting and activated B cells ( Figure S9 ). Still, targeted mutagenesis of the miR-150 binding sites in the c-Myb 3 0 UTR will be ultimately required to determine to what extent contributions of target genes other than c-Myb have to be taken into account in order to fully understand the mutant phenotypes.
Our study suggests a few basic principles of the relationship between miRNAs and their target genes. First, our results suggest that the cellular concentration of a miRNA dictates the degree to which its target genes are affected, and is therefore of key importance in miRNAmediated control. Second, our results highlight the biological relevance of this control mechanism, even when it modulates the concentration of a target protein over a relatively narrow range, as in the present example of a basic transcription factor in the hematopoietic system. The exquisite, quantitatively graded effect on c-Myb expression observed upon graded, moderate expression of miR-150 in an in vivo setting, together with its severe physiological consequences, may be just one example of an intracellular protein exerting its function over a narrow concentration range and being controlled by relatively small changes in the cellular concentration of a miRNA. Indeed, miRNAs may have evolved to exert their function in such contexts, whose analysis requires precise control of miRNA and target gene expression. Third, while bioinformatics analyses predict hundreds of target genes for each miRNA (Rajewsky, 2006) , only a few of these may represent targets with a significant biological function for a particular biological process (Lee et al., 1993; Wightman et al., 1993) . It is therefore possible that gain-and loss-offunction mutations of individual miRNAs can result in phenotypes as distinct as they are seen when protein-coding genes are mutated in similar ways. Indeed, we have seen clear phenotypes in each of three miRNA mutants that we have generated to date (Thai et al., 2007 ; the present work; and C.X., L. Srinivasan, D.P.C., H.C.P., Joel M. Henderson, Jeffrey L. Kutok, and K.R., unpublished data). It is also noteworthy that miR-150 ectopic expression in nonhematopoietic cell lineages in our transgenic mice does not seem to have any obvious adverse physiological effects, although the CAG promoter at the Rosa26 locus drives its expression in most tissues of the mouse. Thus, miRNA-mediated control can also display specificity in terms of functional restriction to a particular differentiation pathway. Finally, our study confirms in an in vivo setting that a perfect match at nucleotide positions 1-8 between a miRNA and its binding site, the evolutionary conservation of the site, and the number of sites are good indicators of function, as proposed in previous publications on target gene predictions.
EXPERIMENTAL PROCEDURES Mice and Cells
To generate mir150 À/À mice, we inserted an frt-flanked pGK-Neo cassette 468 bp upstream of the miR-150 stem loop, with one loxP site placed immediately upstream of the pGK-Neo cassette and the other loxP site placed 146 bp downstream of the miR-150 stem loop. Gene targeting was conducted according to established protocols in the laboratory, using the Bruce 4 ES cells. Mice were generated by injecting targeted ES cells into B6 albino blastocysts and maintained on a pure C57BL/6 background. Mice carrying the targeted allele were bred with deleter-Cre mice (Schwenk et al., 1995) , which deleted the loxP site-flanked 679 bp miR-150 coding genomic region and the frt-flanked pGK-Neo cassette early during embryogenesis, including the germline. The resulting mice were then bred to obtain mir150 homozygous mutants (mir150 À/À mice).
To generate mir150 transgenic mice, we cloned a miR-150-coding genomic DNA fragment into a modified version of pROSA26-1 as previously described (Sasaki et al., 2006) , preceded by the CAG promoter and a loxP-flanked Neo-STOP cassette, followed by an frt-flanked IRES-EGFP cassette and a polyadenylation signal (pA). Gene targeting was conducted according to established protocols in the laboratory, using the ARF1 R19 ES cells (Artemis Pharmaceuticals, Germany). Mice were generated by injecting targeted ES cells into tetraploid blastocysts and maintained on a mixed C57BL/6x129 background. Mice carrying the targeted allele were bred with deleter-Cre mice (Schwenk et al., 1995) , which deleted the Neo-STOP cassette early during embryogenesis, including the germline. The resulting mice were then bred with deleter-Flpe mice (Rodriguez et al., 2000) , which deleted the IRES-EGFP cassette early during embryogenesis, including the germline, too. The offspring from the previous breeding were further bred between siblings. The deletions of Neo-STOP and/or IRES-EGFP are complete in all experimental mice, as examined by PCR on tail DNA samples. The generation of c-Myb +/À mice was reported previously (Bender et al., 2004) , and these mice are maintained on a pure C57BL/6 background.
For determining the expression patterns of miR-150 and c-Myb during lymphocyte development, the following cells were used: pro-B, fetal liver pro-B cell culture from invPE/JHT mice; pre-B 
Western Blot and Northern Blot
These were conducted as previously described (Monticelli et al., 2005; Sasaki et al., 2006) . The anti-Myb monoclonal antibody clone 1-1 (Upstate), anti-mouse Bcl2 monoclonal antibody clone 3F11 (BD PharMingen), rabbit anti-ZFP91 polyclonal antibody (Abcam), and anti-bactin monoclonal antibody clone AC-74 (Sigma) were used for western blot. Foxp1 antibody was previously described (Hu et al., 2006) . DNA oligonucleotides antisense to mature miRNAs were used as probes to detect miRNAs in all northern blots. For quantifying western blots, we used a Fujifilm LAS-3000 imaging system, whose imaging sensor is a high-sensitivity, peltier-cooled chip, recording a maximum of 3.2 megapixels. The sensor collects 16 bits per pixel and this provides a large linear range (four orders of magnitude). We used a Molecular Dynamics Storm860 PhosphorImager to quantify all our northern blots. A PhosphorImager is based on imaging plates that replace normal X-ray film in autoradiographic measurements. An imaging plate consists of a thin layer of special crystals doped with lanthanides. Radioactive radiation excites the crystals, and a latent image of the sample is formed on the plate. The image is read into the computer by scanning the plate with a red laser beam using a dual-optical fiber. The red light further excites the pre-excited phosphor particles, causing emission of blue light. The intensity of this emission is measured with a photomultiplier and used to construct an image of the sample. PhosphorImager systems are linear over a wide dynamic range of signal intensity.
Flow Cytometry
All flow cytometry analyses of mir150 knockout and mir150 transgenic mice were performed on a Becton Dickinson FACSCalibur at the CBR Institute for Biomedical Research, whereas all analyses of c-Myb mice were performed at the flow cytometry facility at the Department of Microbiology, University of Virginia Health System. Data were acquired uncompensated, then compensated and analyzed with the FlowJo analysis program (Tree Star Inc.).
In Vitro Lymphocyte Activation
For determining miR-150 and c-Myb expression levels, B cells from both spleen and peripheral lymph nodes were MACS purified and activated in vitro at a density of 0.5-1 3 10 6 cells/ml with 10 mg/ml of goat anti-mouse IgM, m chain-specific F(ab 0 ) 2 fragment (Jackson Immunoresearch), 0.64 mg/ml of CpG (ODN 1826, Invitrogen), 20 mg/ml of LPS (Sigma), 20 mg/ml of LPS plus 25 ng/ml of recombinant mouse IL-4 (R&D), or 20 mg/ml of LPS plus 2 mg/ml of anti-CD40 (1C10, eBioscience). CD4 T cells from both spleen and peripheral lymph nodes were MACS purified and activated in vitro at a density of 5 3 10 5 cells/ml with 0.25 mg/ml of anti-CD3 (clone 145_2C11, eBioscience) plus 2 mg/ml of anti-CD28 (clone 37.51, eBioscience) in the presence of 20 ng/ml of recombinant murine IL-2 (Peprotech), in a flask coated with 0.3 mg/ml of goat anti-hamster (Jackson Immunoresearch). Activated lymphocytes were harvested at the indicated time points for western blot and northern blot analyses.
Proliferation Analysis MACS-purified B cells and CD4 T cells were labeled with 1 nM CFSE for 10 min at 37 C in 5% CO2, followed by two washes with culture medium. Labeled lymphocytes were activated with indicated stimuli as described above. CFSE fluorescence intensity was determined by flow cytometry at the indicated time points, and data were analyzed by using the proliferation platform of the FlowJo software (Tree Star Inc.). MACS-enriched bone marrow B lineage cells were labeled with PKH26 using the PKH26 Red Fluorescent Cell Linker Kit (Sigma), according to the manufacturer's instructions. Labeled cells were put into the pro-B cell culture system as described below. PKH26 fluorescence intensity was determined by flow cytometry at the indicated time points.
In Vitro Class Switching Assay MACS-purified B cells were plated at a concentration of 1 3 10 6 cells/ ml in 24-well plates and activated for 4 days in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum, L-glutamine, penicillin-streptomycin, nonessential amino acids, sodium pyruvate, HEPES, and 2-mercaptoethanol (Invitrogen) with indicated stimuli to induce class switching to specific isotypes. For IgG1 class switch, cells were stimulated in the presence of 2 mg/ml of anti-CD40 (Clone HM-40-3, eBioscience) plus 25 ng/ml of mouse recombinant IL-4 (Peprotech); for IgA class switch, cells were stimulated in the presence of 25 mg/ml of LPS (Sigma) plus 1 ng/ml of TGFb1; and for IgG3 class-switch, cells were cultured simply in the presence of 25 mg/ml of LPS. After 4 days, cells were stained with the following antibodies: goat anti-mouse IgG1, goat anti-mouse IgA, or goat antimouse IgG3 (Southern Biotech). Class switching was monitored by flow cytometry.
Immunization and ELISA
To determine steady-state serum immunoglobulin levels, unimmunized mice were bled at the age of 8-10 weeks. For T-dependent immune response, 9-week-old mice were immunized with 5 mg of NP36-CCG (4-hydroxy-3-nitrophenylacetyl chicken g-globulin, BiosearchTechnologies) precipitated in Imject Alum (Pierce Biotechnology) intraperitoneally. Mice were bled at indicated time points. Serum samples were analyzed by ELISA with coating and detection antibodies purchased from Southern Biotech (Birmingham, AL) and Biosearch Technologies.
Pro-B Cell Culture
The in vitro pro-B cell culture was performed as previously reported (Rolink et al., 1991) . In short, stroma cells (ST-2 cells) were grown to confluency, treated with 10 mg/ml mitomycin C for 2-3 hr. Cells were washed twice with PBS and incubated with pro-B cell medium before use. B lineage cells were enriched by B220-or CD19-MACS from total bone marrow cells after red blood cell lysis and plated on mitomycin C-treated stroma cells in pro-B cell medium containing 5 ng/ml recombinant human IL-7 purchased from National Institute of Health.
Reporter Assay HEK293T cells were plated into 12-well plates at 3-4 3 10 5 cells/well 24 hr before transfection. 0.2 mg psiCHECK2 (Promega) reporter plasmid containing the c-Myb 3 0 UTR or its mutants and 0.8 mg miRNAexpressing pCXN2 plasmid were cotransfected into each well by using the Fugene 6 transfection reagent (Roche) in triplicates. Luciferase assays were performed 24 hr after transfection by using the Dual-Luciferase Reporter Assay System (Promega) on a Berthold AutoLumat LB953 rack luminometer.
Cell-Cycle Analysis
Cultured cells were washed in protein-free PBS, pelleted, and resuspended in 500 ml cold PBS. One milliliter cold 95% ethanol was added to cells while gently vortexing, followed by a 2 hr incubation on ice. The cells were washed with PBS, resuspended in 200 ml 0.5 mg/ml RNase A, and incubated at 37 C for 20 min. Subsequently, 200 ml of 40 mg/ml propidium iodide was added, and the cells were incubated at room temperature in the dark for 30 min. The samples were analyzed for DNA content by flow cytometry as described above.
Statistics P values were determined by applying Student's two-tailed t test for independent samples, assuming equal variances on all experimental data sets.
Supplemental Data
Supplemental Data include nine figures and two tables and can be found with this article online at http://www.cell.com/cgi/content/full/ 131/1/146/DC1/.
